methoxy polyethylene glycol-epoetin beta

It is used to treat symptomatic anemia caused by chronic kidney disease in adults and children aged 3 months to 18 years.

Form: solution for injection

ATC: B03XA03

Manufacturer: Roche Diagnostics GmbH (manufacturing of unpackaged products, primary packaging, secondary packaging, quality control testing (except biological analysis method "In vivo activity, in normocytemic mice" for stability studies), batch release)

The drug is intended for the treatment of symptomatic anemia associated with chronic kidney disease in adults and children aged 3 months to 18 years.

Form: solution for injection

ATC: B03XA03

Manufacturer: Roche Diagnostics GmbH (manufacturing of unpackaged products, primary packaging, secondary packaging, quality control testing (except biological analysis method "In vivo activity, in normocytemic mice" for stability studies), batch release)